99m as novel imaging agent targeting

HIGHLIGHTS

• who: Brief Report and colleagues from the Institute for Research on Cancer and Aging of Nice, Centre Antoine Lacassagne, CNRS, Université Côte d'Azur, Nice, France have published the research: 99m as Novel Imaging Agent Targeting, in the Journal: (JOURNAL)
• what: The aim of this study was to perform the imaging of in mice models of PDAC with technetium-labeled single-domain antibody (99m Methods:
• future: Future perspectives of this work include evaluation of the sensitivity of 99m Tc-A1 and its ability to phenotype mesothelin-expressing tumors in an orthotopic model . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.